论文部分内容阅读
近年来,白血病治疗有很大进展,不少急性淋巴细胞白血病有希望“治愈”。临床实践证明,白血病患者的年龄、细胞类型等对治疗的反应有密切关系,若无合理可靠的分型标准,各地的治疗方案就难以互相比较。所以探讨急性白血病的分型,对评定治疗、判断预后、探索病因等都有十分重要的意义。目前,血细胞的伊红-美兰染色仍是急性白血病分型的主要根据(国外白血病分型见表1).配合细胞化学、电镜、免疫学等又可
In recent years, great progress has been made in the treatment of leukemia, and many acute lymphoblastic leukemia have the hope of “healing.” Clinical practice has proved that the age of patients with leukemia, cell types, etc. are closely related to the response to treatment, if there is no reasonable and reliable classification criteria, the treatment programs around each other is difficult to compare with each other. Therefore, the classification of acute leukemia, the assessment of treatment, prognosis, explore the cause of all have very important significance. At present, the blood cells of Eosin - Meilan staining is still the main basis for the classification of acute leukemia (foreign leukemia typing shown in Table 1) with cytochemistry, electron microscopy, immunology and so on